U.S. Physical Therapy, Inc. Stock Analysis & AI Score

U.S. Physical Therapy, Inc. (USPH) has an ST Score of 45.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate USPH a Buy, with a price target of $90.00 (+7.4% vs the current price). Our ST Score grades it C+ (45.1/100). The ST Score is a data-driven signal, not a recommendation.

Valuation D+, Profitability C-, Financial Strength B-, Momentum B, Growth C, Forecast C+.

U.S. Physical Therapy, Inc. (USPH) earns a valuation grade of D+, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

U.S. Physical Therapy, Inc. (USPH) earns a growth grade of C, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

U.S. Physical Therapy, Inc. (USPH) earns a profitability grade of C-, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

U.S. Physical Therapy, Inc. (USPH) earns a financial strength grade of B-, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for U.S. Physical Therapy, Inc. (USPH) is $90.00 from 13 analysts, which is +7.4% versus the recent price of $83.76.

U.S. Physical Therapy, Inc. (USPH) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.